https://matjournals.net/pharmacy/index.php/JCTR/issue/feedJournal of Clinical Trials and Regulations (e-ISSN: 2582-4422)2025-08-04T05:43:47+00:00Open Journal Systems<p><strong>JCTR</strong> is a peer-reviewed academic journal which embraces articles related to Clinical Trials and Regulations. The journal with a wide scope in the arena of pharmaceutical sciences covers the topics intended to be of interest to a broad audience of pharmaceutical professionals and ideally placed to serve the needs of their readers. The focuses of the journal are ICH/GCP, DMF and Dossier, Clinical Research, Pharmacovigilance, USDFA/EU, EU Clinical Trial developments, Manufacturing, Quality Control, GCP, ICH, Ethics, IRB, Regulations for Clinical Trials, Clinical Trials Data Management.</p>https://matjournals.net/pharmacy/index.php/JCTR/article/view/222Hypochondria2025-08-04T05:38:57+00:00Ravina Ranigoyalraveena7@gmail.com<p><em>Hypochondria are a psychological disorder characterized by excessive thoughts about having a serious illness in the absence of adequate medical evidence. Patients tend to misinterpret normal bodily sensations or small symptoms as indications of a serious disease, triggering significant anxiety and distress. The article publishes an exhaustive study of hypochondria, treating its symptoms, causes, impacts, and treatment possibilities. It starts with the symptoms of hypochondria since the discord er is characterized by excessive health-related anxiety, repeated self-examinations, persistent fears about ill health, and avoidance of medical environments. It is further emphasized that these symptoms must be differentiated from others in distinct medical conditions. The article then examines all contributing factors to hypochondria, such as genetic predisposition, traumatic health experiences, psychological factors (e.g., stress and anxiety), and cognitive misinterpretations of bodily sensations. These overlapping factors result in further development and the even continued presence of health anxiety within an individual. The article then makes two types of hypochondria - health anxiety without important physical symptoms and health anxiety with mild physical symptoms - further stressing the pertinence of recognizing these types for correct diagnosis and treatment. In addition, the article talks about the aspect that highlights the positive effect of hypochondria on patient care and mental health support systems. It presents the outline of the diagnostic process, which comprises clinical evaluation, reviewing the medical history, and ruling out other health conditions. The role of Cognitive Behaviour Therapy (CBT) in hypochondria treatment is also discussed in the article; it explains the techniques and also the efficacy of such treatment in hypochondria cases. The article also focuses on the severity of health anxiety as well as the different facets where it touches on one's daily living, emotional being, and relationships. In short, the article emphasizes the importance of improving the quality of life of hypochondriacs through recognition, diagnosis, and treatment. It calls for a comprehensive support and interventional resource mobilization in the management of hypochondria.</em></p>2025-08-04T00:00:00+00:00Copyright (c) 2025 Journal of Clinical Trials and Regulations (e-ISSN: 2582-4422)